Quarterly report pursuant to Section 13 or 15(d)

Summary of Changes in Stockholders Equity (Detail)

v3.20.2
Summary of Changes in Stockholders Equity (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance $ 1,098,780 $ 1,265,565 $ 1,448,322 $ 1,527,719 $ 1,463,786 $ 1,456,117 $ 1,448,322 $ 1,456,117
Issuance of share based awards and share based awards compensation expense 4,428 4,321 4,111 3,840 3,677 2,970    
Stock withholdings related to share based awards that vested (67) (107) (2,691)   (300) (1,947)    
Dividends paid to stockholders [1]     (42,311) (39,832) (39,823) (39,797)    
Dividends paid to noncontrolling interests     (392) (294) (294) (1,000)    
Dividends accrued on unvested restricted stock unit awards     (256) [1] (189) [1] (189) [1] (108) [1] (257) (486)
Net income (loss) (148,036) (170,816) (59,422) 31,955 101,861 33,193 (378,274) 167,009
Issuance of convertible senior notes 97,359              
Tax impact of convertible notes issued 10,960              
Call options purchased (142,094)              
Proceeds from issuance of warrants 89,424              
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements 6,528 849 (24,171) (1,291) (5,902) (3,311) (16,794) (10,504)
Other comprehensive loss in equity method investments 0     (49) (22) (71) 0 (142)
Amortization of accumulated losses for amended swap agreements 2,669 2,669            
Foreign currency translation adjustments (1,503) (3,702) (57,625) (25,408) 4,925 755    
Total Equity, Ending Balance 1,018,448 1,098,780 1,265,565 1,496,451 1,527,719 1,463,786 1,018,448 1,496,451
Cumulative Effect, Period of Adoption, Adjustment                
Shareholders Equity [Line Items]                
Cumulative effect of change in accounting principle, net of taxes           16,985    
Common Stock                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance 122 122 122 122 121 121 122 121
Issuance of share based awards and share based awards compensation expense 1       1      
Total Equity, Ending Balance 123 122 122 122 122 121 123 122
Treasury Stock                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance (84,365) (84,258) (81,567) (81,506) (81,206) (79,259) (81,567) (79,259)
Stock withholdings related to share based awards that vested (67) (107) (2,691)   (300) (1,947)    
Total Equity, Ending Balance (84,432) (84,365) (84,258) (81,506) (81,506) (81,206) (84,432) (81,506)
Additional Paid-In-Capital                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance 1,178,471 1,174,150 1,170,039 1,162,070 1,158,394 1,155,424 1,170,039 1,155,424
Issuance of share based awards and share based awards compensation expense 4,427 4,321 4,111 3,840 3,676 2,970    
Issuance of convertible senior notes 97,359              
Tax impact of convertible notes issued 10,960              
Call options purchased (142,094)              
Proceeds from issuance of warrants 89,424              
Total Equity, Ending Balance 1,238,547 1,178,471 1,174,150 1,165,910 1,162,070 1,158,394 1,238,547 1,165,910
Retained Earnings                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance 414,785 585,174 687,332 757,226 696,267 686,459 687,332 686,459
Dividends paid to stockholders [1]     (42,311) (39,832) (39,823) (39,797)    
Dividends accrued on unvested restricted stock unit awards [1]     (256) (189) (189) (108)    
Net income (loss) (147,592) (170,389) (59,591) 31,353 100,971 32,728    
Total Equity, Ending Balance 267,193 414,785 585,174 748,558 757,226 696,267 267,193 748,558
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment                
Shareholders Equity [Line Items]                
Cumulative effect of change in accounting principle, net of taxes           16,985    
Accumulated Other Comprehensive Loss                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance (422,092) (421,908) (340,112) (322,633) (321,634) (319,007) (340,112) (319,007)
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements 6,528 849 (24,171) (1,291) (5,902) (3,311)    
Other comprehensive loss in equity method investments       (49) (22) (71)    
Amortization of accumulated losses for amended swap agreements 2,669 2,669            
Foreign currency translation adjustments (1,503) (3,702) (57,625) (25,408) 4,925 755    
Total Equity, Ending Balance (414,398) (422,092) (421,908) (349,381) (322,633) (321,634) (414,398) (349,381)
Total Cinemark Holdings, Inc.'s Stockholders' Equity                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance 1,086,921 1,253,280 1,435,814 1,515,279 1,451,942 1,443,738 1,435,814 1,443,738
Issuance of share based awards and share based awards compensation expense 4,428 4,321 4,111 3,840 3,677 2,970    
Stock withholdings related to share based awards that vested (67) (107) (2,691)   (300) (1,947)    
Dividends paid to stockholders [1]     (42,311) (39,832) (39,823) (39,797)    
Dividends accrued on unvested restricted stock unit awards [1]     (256) (189) (189) (108)    
Net income (loss) (147,592) (170,389) (59,591) 31,353 100,971 32,728    
Issuance of convertible senior notes 97,359              
Tax impact of convertible notes issued 10,960              
Call options purchased (142,094)              
Proceeds from issuance of warrants 89,424              
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements 6,528 849 (24,171) (1,291) (5,902) (3,311)    
Other comprehensive loss in equity method investments       (49) (22) (71)    
Amortization of accumulated losses for amended swap agreements 2,669 2,669            
Foreign currency translation adjustments (1,503) (3,702) (57,625) (25,408) 4,925 755    
Total Equity, Ending Balance 1,007,033 1,086,921 1,253,280 1,483,703 1,515,279 1,451,942 1,007,033 1,483,703
Total Cinemark Holdings, Inc.'s Stockholders' Equity | Cumulative Effect, Period of Adoption, Adjustment                
Shareholders Equity [Line Items]                
Cumulative effect of change in accounting principle, net of taxes           16,985    
Noncontrolling Interests                
Shareholders Equity [Line Items]                
Total Equity, Beginning Balance 11,859 12,285 12,508 12,440 11,844 12,379 12,508 12,379
Dividends paid to noncontrolling interests     (392) (294) (294) (1,000)    
Net income (loss) (444) (427) 169 602 890 465    
Total Equity, Ending Balance $ 11,415 $ 11,859 $ 12,285 $ 12,748 $ 12,440 $ 11,844 $ 11,415 $ 12,748
[1] Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the nine months ended September 30, 2020 and 2019